Richard D. Drake

987 total citations
20 papers, 716 citations indexed

About

Richard D. Drake is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Richard D. Drake has authored 20 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Reproductive Medicine, 7 papers in Obstetrics and Gynecology and 5 papers in Surgery. Recurrent topics in Richard D. Drake's work include Ovarian cancer diagnosis and treatment (11 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Vascular Tumors and Angiosarcomas (2 papers). Richard D. Drake is often cited by papers focused on Ovarian cancer diagnosis and treatment (11 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Vascular Tumors and Angiosarcomas (2 papers). Richard D. Drake collaborates with scholars based in United States and South Korea. Richard D. Drake's co-authors include David S. Miller, Amanda N. Fader, Peter G. Rose, Heidi Gibbons, Allison E. Axtell, Paola A. Gehrig, Laura J. Havrilesky, Erin Tuller, Warner K. Huh and David M. O’Malley and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Richard D. Drake

20 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard D. Drake United States	15	341	336	159	155	109	20	716
P. Iyengar Canada	12	154 0.5×	130 0.4×	152 1.0×	150 1.0×	109 1.0×	24	517
Stelios Fotiou Greece	17	311 0.9×	286 0.9×	117 0.7×	107 0.7×	88 0.8×	51	689
Steven DeCesare United States	9	260 0.8×	240 0.7×	243 1.5×	77 0.5×	141 1.3×	13	695
Hiroaki Kase Japan	16	448 1.3×	453 1.3×	94 0.6×	167 1.1×	40 0.4×	35	834
Patricia Rose United States	8	366 1.1×	311 0.9×	156 1.0×	143 0.9×	62 0.6×	18	708
D. Paraïso France	14	203 0.6×	401 1.2×	272 1.7×	149 1.0×	96 0.9×	35	689
Stacy Nerenstone United States	7	188 0.6×	281 0.8×	122 0.8×	74 0.5×	81 0.7×	9	589
Birgit Volgger Austria	11	134 0.4×	371 1.1×	257 1.6×	82 0.5×	46 0.4×	17	644
Masamichi Hiura Japan	16	750 2.2×	705 2.1×	198 1.2×	184 1.2×	97 0.9×	50	1.2k
Fumitoshi Terauchi Japan	10	262 0.8×	511 1.5×	211 1.3×	142 0.9×	70 0.6×	31	716

Countries citing papers authored by Richard D. Drake

Since Specialization

Citations

This map shows the geographic impact of Richard D. Drake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard D. Drake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard D. Drake more than expected).

Fields of papers citing papers by Richard D. Drake

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard D. Drake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard D. Drake. The network helps show where Richard D. Drake may publish in the future.

Co-authorship network of co-authors of Richard D. Drake

This figure shows the co-authorship network connecting the top 25 collaborators of Richard D. Drake. A scholar is included among the top collaborators of Richard D. Drake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard D. Drake. Richard D. Drake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Starbuck, Kristen, Richard D. Drake, G. Thomas Budd, & Peter G. Rose. (2016). Treatment of Advanced Malignant Uterine Perivascular Epithelioid Cell Tumor with mTOR Inhibitors: Single-institution Experience and Review of the Literature. Anticancer Research. 36(11). 6161–6164. 36 indexed citations

Herzog, Thomas J., Bradley J. Monk, Peter G. Rose, et al.. (2014). A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube. Gynecologic Oncology. 132(3). 517–525. 19 indexed citations

Simpkins, Fiona, Richard D. Drake, Pedro F. Escobar, et al.. (2014). A phase II trial of paclitaxel, carboplatin, and bevacizumab in advanced and recurrent endometrial carcinoma (EMCA). Gynecologic Oncology. 136(2). 240–245. 42 indexed citations

O’Malley, Margaret, et al.. (2013). Prevalence of occult gynecologic malignancy at the time of risk reducing and nonprophylactic surgery in patients with Lynch syndrome. Gynecologic Oncology. 132(2). 434–437. 15 indexed citations

Dizon, Don S., John A. Blessing, Richard T. Penson, et al.. (2012). A phase II evaluation of belinostat and carboplatin in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal carcinoma: A gynecologic oncology group study. Gynecologic Oncology. 125(2). 367–371. 80 indexed citations

Allende, Daniela, Richard D. Drake, & Longwen Chen. (2010). Mural Nodules of Clear Cell Carcinoma in a Mucinous Borderline Tumor of the Ovary: A Case Report. Pathology Research International. 2010. 1–4. 3 indexed citations

Fader, Amanda N., Christa Nagel, Allison E. Axtell, et al.. (2009). Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes. Gynecologic Oncology. 112(3). 558–562. 66 indexed citations

Fader, Amanda N., Richard D. Drake, David M. O’Malley, et al.. (2009). Platinum/taxane‐based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma. Cancer. 115(10). 2119–2127. 120 indexed citations

Shahabi, Shohreh, et al.. (2009). The relevance of rising CA-125 levels within the normal range in predicting recurrence in patients with advanced stage ovarian cancer: A validation study. Journal of Clinical Oncology. 27(15_suppl). e16521–e16521. 1 indexed citations

10.

Miller, David S., John A. Blessing, Richard D. Drake, et al.. (2009). A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologic Oncology. Gynecologic Oncology. 115(3). 443–446. 30 indexed citations

11.

Rose, Peter G., Richard D. Drake, Patricia S. Braly, et al.. (2009). Preliminary results of a phase II study of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube. Journal of Clinical Oncology. 27(15_suppl). 5546–5546. 17 indexed citations

12.

Drake, Richard D., et al.. (2007). Simplifying the preevacuation testing strategy for patients with molar pregnancy.. PubMed. 52(8). 685–8. 1 indexed citations

13.

Drake, Richard D., Gautam G. Rao, Donald D. McIntire, David S. Miller, & John O. Schorge. (2006). Gestational trophoblastic disease among Hispanic women: A 21-year hospital-based study. Gynecologic Oncology. 103(1). 81–86. 14 indexed citations

14.

Li, Andrew J., Robert Giuntoli, Richard D. Drake, et al.. (2005). Ovarian Preservation in Stage I Low-Grade Endometrial Stromal Sarcomas. Obstetrics and Gynecology. 106(6). 1304–1308. 75 indexed citations

15.

Drake, Richard D. & John O. Schorge. (2005). The activity of taxanes in the treatment of sex cord-stromal ovarian tumors. The Women s Oncology Review. 5(1). 31–32. 2 indexed citations

16.

Rao, Gautam G., Paula Rogers, Richard D. Drake, Vuong Nguyen, & Robert L. Coleman. (2004). Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer. Gynecologic Oncology. 96(1). 168–172. 29 indexed citations

17.

Drake, Richard D., et al.. (2004). Oral dexamethasone attenuates Doxil®-induced palmar-plantar erythrodysesthesias in patients with recurrent gynecologic malignancies. Gynecologic Oncology. 94(2). 320–324. 45 indexed citations

18.

Schorge, John O., Richard D. Drake, Hang Lee, et al.. (2004). Osteopontin as an Adjunct to CA125 in Detecting Recurrent Ovarian Cancer. Clinical Cancer Research. 10(10). 3474–3478. 75 indexed citations

19.

Pellegrini, Arthur E., Richard D. Drake, & Stephen J. Qualman. (1995). Spindle cell hemangioendothelioma: A neoplasm associated with Maffucci's syndrome. Journal of Cutaneous Pathology. 22(2). 173–176. 26 indexed citations

20.

Guin, Jere D., et al.. (1984). The effect of quenching agents on contact urticaria caused by cinnamic aldehyde. Journal of the American Academy of Dermatology. 10(1). 45–51. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact